Henry Schein Inc HS2
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HS2 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- €68.48
- Day Range
- €68.18–68.18
- 52-Week Range
- €40.69–—
- Bid/Ask
- €68.52 / €68.68
- Market Cap
- €8.73 Bil
- Volume/Avg
- 0 / 1
Key Statistics
- Price/Earnings (Normalized)
- 16.93
- Price/Sales
- 0.78
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 2.37%
Company Profile
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Core
- Total Number of Employees
- 25,000
- Website
- https://www.henryschein.com
Comparables
Valuation
|
Metric
|
HS2
|
PHR
|
TRHC
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.93 | — | — |
Price/Book Value | 2.64 | 5.39 | — |
Price/Sales | 0.78 | 3.68 | 0.78 |
Price/Cash Flow | 12.57 | — | — |
Price/Earnings
HS2
PHR
TRHC
Financial Strength
|
Metric
|
HS2
|
PHR
|
TRHC
|
|---|---|---|---|
Quick Ratio | 0.77 | 1.38 | 1.28 |
Current Ratio | 1.75 | 1.78 | 1.57 |
Interest Coverage | 5.73 | −74.19 | −8.04 |
Quick Ratio
HS2
PHR
TRHC
Profitability
|
Metric
|
HS2
|
PHR
|
TRHC
|
|---|---|---|---|
Return on Assets (Normalized) | 4.99% | −21.95% | −2.75% |
Return on Equity (Normalized) | 13.42% | −30.21% | — |
Return on Invested Capital (Normalized) | 7.53% | −29.40% | −1.87% |
Return on Assets
HS2
PHR
TRHC
Medical Distribution Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MCK
| McKesson Corp | Bzkvhbglt | Skvbdrk | $72.2 Bil | |
COR
| Cencora Inc | Jcltnxmq | Gwzfj | $44.2 Bil | |
CAH
| Cardinal Health Inc | Ksxkyfmv | Wxvylsg | $24.0 Bil | |
SHTDF
| Sinopharm Group Co Ltd | — | Mczqwc | $8.9 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Hbzqnp | $8.9 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Nftxrs | $8.6 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Sprwb | $8.6 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Gpyvcw | $8.4 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Byxh | $3.1 Bil | |
MEPDF
| Medipal Holdings Corp | — | Qzxf | $3.1 Bil |